Press ReleasesAvida Labs Appointed By Dermactiva To Produce And Manufacture...

Avida Labs Appointed By Dermactiva To Produce And Manufacture Its New Skin And Cosmetics Range

-

HEALTHCARE Branding Ltd has appointed Avida Labs, Europe’s leading CBD manufacturing business, to produce its new soon to be launched skin and body care range under the Dermactiva Brand. 

Using Dermactiva’s heritage formulations drawing on 25 years of Colombian expertise, Avida Labs will formulate and manufacture Dermactiva’s three new products using its own high-quality CBD oil, cultivated and produced at its GMP compliant, ISO certified facility in North-East Colombia. The new range is set to launch in Summer 2022.

Avida Labs is the manufacturing arm of Avida Global. Avida Labs offers companies, from early-stage entrepreneurs to major brands looking to get a foothold in the CBD industry, access to a suite of services including in-house formulation and testing, research & development, bottling, packaging and design. Customers can choose from a broad variety of CBD oils including Avida Global’s own.

Nathan Whitman, Managing Director, Avida Labs commented: “We are proud to partner with Dermactiva for this exciting new launch. We share many synergies not least our shared Colombian heritage and our ethos of prioritising purity and traceability across our entire ecosystem.” 

Claudia Avila-Batchelor, Dermactiva’s Colombian co-founder emphasised her brand’s unique position: “Colombia’s terrain and climate produce arguably the best natural Cannabis in the world. We are thrilled to be able to offer our unique formulations with the premium Colombian oil that Avida Global are exclusively blending for us. This will be a game-changer in the industry and for consumers.” 

Latest news

MGC Pharmaceuticals Releases Update On CimetrA Clinical Trial Progress In USA

MGC Pharmaceuticals Ltd (ASX, LSE: MXC, ‘MGC Pharma’ or ‘the Company’), a European based bio-pharma company specialising in the production and development...

European Cannabis Stocks Review: Akanda’s ‘Concerned Shareholders’ Oust All Directors Except CEO To Prevent ‘Potentially Irreparable Harm’ – More From Goodbody Health & Chill...

It has been another week of positive developments for the cannabis industry across Europe, with yet more markets making...

Analysis Shows UK Market Could Grow To Over £1bn By 2026 As London Prepares To Host Europe’s Leading Cannabis Conference

ANALYSIS shows UK market could grow to over £1bn by 2026 as London prepares to host Europe’s leading cannabis...

Medical Cannabis Could Be Available In Spain By The End Of The Year

SPAIN could now see the regulation and distribution of medical cannabis rolled out before the end of the year...

New UK Company Heralds Its ‘Unique’ Medical Cannabis Delivery Mechanism

CANNABIS extraction and formulations specialist 113 Botanicals is in the process of securing Good manufacturing Practice (GMP) compliance for...

German Cannabis Bill By Year End With Adult-Use Launch Likely In Early 2024

GERMANY’s draft cannabis law should be ready by the end of the year with the launch of its adult-use...

Must read

You might also likeRELATED
Recommended to you